NVS Oncology

What's going on with so many departing NVS Oncology in the last few weeks? Heard of a few Sr. Reps that left.

 

My guess would be better pay and the fact there is just way too many of us now do to the addition of the GSK reps. 8 of us in a territory now.... I mean really! Come on now Novartis! Should be interesting when we go to schedule lunches for 2016!!

 

Retained less than 50% of the GSK reps. If the two divisions were still separate, there would be more reps in the field total...just wearing separate name badges. We actually did the physician offices a favor.

 

Guess why? Been there, done that, never again.....bunch of post or pre-menopausal women with leading positions making the lives of people under their umbrellas so miserable. Oncology is notoriously famous for the bitching behind your back and fake smiles. And don't get me started on the lack of communication or transparency within the team, no one knows what the other does. Not only in Basel this is also applicable to the US Onc team too. Yuuukkk... if you love yourself avoid this sector of Novartis at all costs.

 

Unfortunately it seems US oncology is being managed like pharma. That will never work in the real oncology world. This market is about actual conversations not catch phrases.

 

Any guess for re alignment of lay offs? I heard rumors of lay offs around thanksgiving. Hope these rumors are just rumors and no body looses his or her job.

 

Most likely Christmas Eve. Isn't that the Novartis motis operandi?

 

The launch of Ibrance is crushing Afinitor. Layoffs will be here well before Thanksgiving. Think more like Labor Day. The slide is brutal.

 

Any info on Hematology Rep position posted? What drugs and would you recommend applying?
Thanks for the info.

 

50 percent of those jobs will not exist a year from now. Apply at your own risk.

 

Thanks for the info.

 

Gleevec goes generic in Feb. 2016 and Afinitor is falling like a rock after the Ibrance launch.

Pretty spot on.

 

Hem DOA/MIA

 

Farydik is DOA.
Tasigna has about 6 months to live before generic imatinib hits
GSK drugs were dogs....hey, throw more marketing at them....that makes 'em better

and yes reps are getting out as soon as they can

 

This division has always be a cluster fuck with "pods' and mirror territories. MD's don't need to see numerous reps from the same company and hear the "canned" presentations marketing creates.

With GSK reps now on board layoffs will come by the end of the year as NVS thins the herd like they have done the past couple of years!

 

When was the last time you were taught about the clinical sale, instead of a few marketing points?

 

This is a funny post. So I take it the peri-menopausal women leaders are awesome!

 

NVS oncology is a great place to be at and with so many products and strong pipe line there should not be much concern.